Acute normovolemic hemodilution is not beneficial in patients undergoing primary elective valve surgery

被引:11
作者
Virmani, Sanjula [1 ]
Tempe, Deepak K. [1 ]
Pandey, Bhuvan C. [1 ]
Cheema, Amandeep S. [1 ]
Datt, Vishnu [1 ]
Garg, Mukesh [1 ]
Banerjee, Amit [2 ]
Wadhera, Ashoo [1 ]
机构
[1] GB Pant Hosp, Dept Anaesthesiol & Intens Care, New Delhi, India
[2] GB Pant Hosp, Dept Cardiothorac Surg, New Delhi, India
关键词
Acute normovolemic hemodilution; elective valve surgery; cardiac surgery;
D O I
10.4103/0971-9784.58832
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The objective of this study was to evaluate the effectiveness of acute normovolemic hemodilution (ANH) as a sole method of reducing allogenic blood requirement in patients undergoing primary elective valve surgery. One hundred eighty eight patients undergoing primary elective valve surgery were prospectively randomized into two groups: Group I (n= 100) acted as control and in Group II (n= 88) autologous blood was removed (10% of estimated blood volume in patients with hemoglobin (Hb) > 12g% and 7% when the Hb was < 12g%) in the pre-cardiopulmonary bypass (CPB) period for subsequent re-transfusion after protamine administration. The autologous blood withdrawn was replaced simultaneously with an equal volume of hydroxyl-ethyl starch solution. Banked blood was transfused in both the groups when Hb was <= 6g% on CPB and <= 8g% after CPB. Platelets were transfused when the count fell to < 100x10(9)/L and fresh frozen plasma (FFP) was transfused whenever there was diffuse bleeding with laboratory evidence of coagulopathy. The two groups were comparable as regards demographic data, type of surgical procedures performed, duration of CPB and ischemia, duration of elective ventilation and re-exploration for excessive bleeding. The autologous blood withdrawn in patients with Hb >= 12g% was 288.3 +/- 69.4 mL and 244.4 +/- 41.3 mL with Hb< 12g% (P= NS). The Hb concentration (g%) was comparable pre-operatively (Group I= 12.1 +/- 1.6, Group II= 12.4 +/- 1.4), on postoperative day 1 (Group I= 10.3 +/- 1.1, Group II= 10.6 +/- 1.2) and day 7 (Group I= 10.9 +/- 1.5, Group II= 10.4 +/- 1.5). However, the lowest Hb recorded on CPB was significantly lower in Group II (Group I= 7.7 +/- 1.2, Group II= 6.7 +/- 0.9, P< 0.05). There was no difference in the chest tube drainage (Group I= 747.2 +/- 276.5 mL, Group II= 527.6 +/- 399.5 mL), blood transfusion (Group I= 1.1 +/- 1.0 units vs. Group II= 1.3 +/- 1.0 units intra-operatively and Group I= 1.7 +/- 1.2 units vs. Group II= 1.7 +/- 1.4 units post-operatively) and FFP transfusion (Group I= 581.4 +/- 263.4 mL, Group II= 546.5 +/- 267.8 mL) in the two groups. We conclude that low volume autologous blood pre-donation does not seem to provide any added advantage as a sole method of reducing allogenic blood requirement in primary elective valve surgery.
引用
收藏
页码:34 / 38
页数:5
相关论文
共 19 条
[1]   Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis [J].
Bryson, GL ;
Laupacis, A ;
Wells, GA .
ANESTHESIA AND ANALGESIA, 1998, 86 (01) :9-15
[2]   Intraoperative low-volume acute normovolemic hemodilution in adult open-heart surgery [J].
Casati, V ;
Speziali, G ;
D'Alessandro, C ;
Cianchi, C ;
Grasso, MA ;
Spagnolo, S ;
Sandrelli, L .
ANESTHESIOLOGY, 2002, 97 (02) :367-373
[3]   Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Clinical Practice Guideline [J].
Ferraris, Victor A. ;
Ferraris, Suellen P. ;
Saha, Sibu P. ;
Hessel, Eugene A., II ;
Haan, Constance K. ;
Royston, B. David ;
Bridges, Charles R. ;
Higgins, Robert S. D. ;
Despotis, George ;
Brown, Jeremiah R. ;
Spiess, Bruce D. ;
Shore-Lesserson, Linda ;
Stafford-Smith, Mark ;
Mazer, C. David ;
Bennett-Guerrero, Elliott ;
Hill, Steven E. ;
Body, Simon .
ANNALS OF THORACIC SURGERY, 2007, 83 (05) :27-86
[4]   Medical progress - Transfusion medicine (First of two parts) - Blood transfusion [J].
Goodnough, LT ;
Brecher, ME ;
Kanter, MH ;
AuBuchon, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :438-447
[5]  
HALLOWELL P, 1972, J THORAC CARDIOV SUR, V64, P941
[6]  
Hohn L, 2002, ANESTHESIOLOGY, V96, P276
[7]  
KAPLAN JA, 1977, J THORAC CARDIOV SUR, V74, P4
[8]   Perceptions and preferences of autologous blood donors [J].
Lee, SJ ;
Liljas, B ;
Churchill, WH ;
Popovsky, MA ;
Stowell, CP ;
Cannon, ME ;
Johannesson, M .
TRANSFUSION, 1998, 38 (08) :757-763
[9]   Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index [J].
Marcucci, C ;
Madjdpour, C ;
Spahn, DR .
BRITISH MEDICAL BULLETIN, 2004, 70 (01) :15-28
[10]   SEVERE OUTCOMES OF ALLOGENEIC AND AUTOLOGOUS BLOOD DONATION - FREQUENCY AND CHARACTERIZATION [J].
POPOVSKY, MA ;
WHITAKER, B ;
ARNOLD, NL .
TRANSFUSION, 1995, 35 (09) :734-737